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Reflecting ŽŶůĞŵĞŶƐĞƚĂů ?  ?^ƵƉƉŽƌƚŝŶŐŚĞĂůƚŚƐǇƐƚĞŵƐ ŝŶƵƌŽƉĞ ?ĂĚĚĞĚǀĂůƵĞŽĨhĂĐƚŝŽŶƐ ?  ?
HEPL (2014) 49: Europeanising health post-crisis  
Tamara Hervey, Jean Monnet Professor of EU Law, School of Law, University of Sheffield, 
t.hervey@sheffield.ac.uk 
Introduction 
Many in the health policy community are highly critical of the European Union and its involvement in 
health. ůĞŵĞŶƐĞƚĂů ?ƐƉĂƉĞƌŝƐĂƌĞĨƌĞƐŚŝŶŐůǇďĂůĂŶĐĞĚĂŶĂůǇƐŝƐĂŶĚĂƐƐĞƐƐŵĞŶƚ ?/ƚsummarises the 
 ‘ƐƚĂŶĚĂƌĚŶĂƌƌĂƚŝǀĞ ?ŽĨƚŚĞĚĞƚƌŝŵĞŶƚĂůŝŵƉĂĐƚƐŽĨhůĂǁĂŶĚƉŽůŝĐǇŽŶŶĂƚŝŽŶĂůŚĞĂůƚŚƐǇƐƚĞŵƐ. But 
it also illuminates an ŝŵƉŽƌƚĂŶƚĐŽƵŶƚĞƌďĂůĂŶĐĞŽĨ ‘ŚŝĚĚĞŶ ?ĂƐƉĞĐƚƐŽĨhŚĞĂůƚŚƉŽůŝĐǇ ? These have 
the potential to improve health across the EU, even in the post-crisis era of public spending austerity. 
The conclusion  W ƚŚĂƚŽŶďĂůĂŶĐĞ ‘hŝŶǀŽůǀĞŵĞŶƚĐĂŶĂĚĚďŝĂƐĞƐĂŶĚƉƌŽďůĞŵƐƉƌĞǀŝŽƵƐůǇƵŶŬŶŽǁŶ
ĂƚŶĂƚŝŽŶĂůůĞǀĞůƐ ? ?ůĞŵĞŶƐĞƚĂů ? ? ? ? ? ?  W is thus more persuasive than that in other analyses. 
This commentary considers three inter-related ĂƐƉĞĐƚƐŽĨůĞŵĞŶƐĞƚĂů ?ƐƉŝĞĐĞ PƚŚĞƐĐŽƉĞŽĨĞŶƋƵŝƌǇ ?
the multiple logics of EU health policy; and the Europeanisation of health, following the Eurozone 
ĐƌŝƐŝƐ ?ǁŚŝĐŚŚĂƐŚĂĚƐŝŐŶŝĨŝĐĂŶƚĞĨĨĞĐƚƐŽŶŚĞĂůƚŚƉŽůŝĐŝĞƐǁŝƚŚŝŶƚŚĞh ?ƐDĞŵďĞƌt^ates (Fahy 2012; 
Kentikelenis and Papanicolas 2012; Greer 2014). 
 
Core areas/scope of EU health policy 
dŚĞƉĂƉĞƌ ?Ɛ exploration of EU health policy rests on five selected EU policies with a health dimension. 
dŚĞƐĞ ĂƌĞ P ƉĂƚŝĞŶƚ ĂŶĚ ŚĞĂůƚŚ ƉƌŽĨĞƐƐŝŽŶĂů ŵŽďŝůŝƚǇ ?  ‘ĂĐƚŝǀĞ ĂŐĞŝŶŐ ? ? ƚŚĞ ƉƵďůŝĐ ŚĞĂůƚŚ  ‘ĂĐƚŝŽŶ
ƉƌŽŐƌĂŵŵĞ ? ? h ƐƚƌƵĐƚƵƌĂů ĨƵŶĚŝŶŐ ĨŽƌ ĞĐŽŶŽŵŝĐ ĚĞǀĞůŽƉŵĞŶƚ ? ĂŶĚ  ‘ƌĞĨůĞĐƚŝŽŶ ƉƌŽĐĞƐƐĞƐ ? ĂŵŽŶŐ
senior governmental actors. Implicitly, Clemens et al claim that these are, if not the core of EU 
health policy, at least a sufficiently representative selection of examples from which to generalise 
about EU health policy.  
Comparing this choice of examples (and claims) with the literature on EU health law and policy 
reveĂůƐƚŚĂƚůĞŵĞŶƐĂƚĂů ?ƐĐŚŽŝĐĞĚĞƉĂƌƚƐĨƌŽŵĞǆŝƐƚŝŶŐ ůŝƚĞƌĂƚƵƌĞ ŝŶƐĞǀĞƌĂůƌĞƐƉĞĐƚƐ. Historically, 
public health policy enjoys a more ŝŵƉŽƌƚĂŶƚƉŽƐŝƚŝŽŶƚŚĂŶ ŝŶůĞŵĞŶƐ ?ĞƚĂů ?Ɛpiece, which covers 
only the EU public health programmes. General EU public health policy has a much wider meaning 
and significance. It interacts with the law of the internal market, as well as World Trade Organisation 
law about trade in products which are, or may be, harmful for health, such as tobacco or alcohol 
(Hervey and McHale 2004; McKee et al 2010; Hervey and McHale 2015). The role of food in public 
health, especially as Europe emerged from the starvation following World War II, means that the 
h ?ƐĐŽŵŵŽŶĂŐƌŝĐƵůƚƵƌĂůƉŽůŝĐǇŝƐĂŶŝŵƉŽƌƚĂŶƚƐŝƚĞĨŽƌŝƚƐŚĞĂůƚŚƉŽůŝĐǇ ?&ŽŽĚƐafety has become a 
ǀŝƚĂůƉĂƌƚŽĨƚŚĞh ?ƐŚĞĂůƚŚƉƌŽƚĞĐƚŝŽŶƉŽůŝĐǇ ?ĞƐƉĞĐŝĂůůǇĨŽůůŽǁŝŶŐƚŚĞ^ ?ǀ:ĂĨĨĂŝƌŽĨƚŚĞ ? ? ? ?Ɛ
(Grant 2012).  Early texts on EU health policy (such as McCarthy and Rees 1992) are only on public 
health, and interest continues (Greer and Kurzer 2013).   
Also dating to the h ?Ɛfoundational period, pharmaceutical policy continues to be central to EU 
health policy (Hermans et al 1992; Normand and Vaughan 2001; Busse et al 2002; Hervey 2002; 
McKee et al 2003; Mossialos and McKee 2004; Hervey and McHale 2004; Mossialos et al 2010; 
Hancher and Sauter 2012; Greer and Kurzer 2013). Recent developments in pharmaceuticals and 
medical devices technology (Flear et al 2013) mean that EU policy on human blood, tissue and 
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organs is important (Hervey and Black 2005; Lee 2010; Altenstetter 2011; Farrell 2012; Stokes 2013; 
Flear 2015).  In the post-crisis Europe, as Clemens et al note, new health technologies are 
constructed as contributing to economic development and growth at least as much as to health per 
se. But the regulation of the human body also ŚĂƐ ŝŶƚĞƌĂĐƚŝŽŶƐ ǁŝƚŚ ƵƌŽƉĞ ?Ɛ ůŽŶŐ-standing 
commitment to human rights (Hervey 2003; McHale 2010; Herrmann and Toebes 2012; Harmon et 
al 2013; Peers et al 2014), a part of EU health policy not considered by Clemens et al. 
There is general agreement that EU health policy includes mobility of patients and health care 
professionals, and the consequences of EU free movement and competition law for national health 
care systems (Mossialos et al 2002; Hervey and McHale 2004; Nihoul and Simon 2005; Thomson et al 
2009; Mossialos et al 2010; Van de Gronden et al 2011; Hancher and Sauter, 2012; Greer and Kurzer 
2013; Hervey and McHale 2015). A small, but growing, body of literature (Jarman 2013, 2014; 
Hervey and McHale 2015) is concerned with the external ĞĨĨĞĐƚƐŽĨƚŚĞh ?ƐŚĞĂůƚŚƉŽůŝĐǇ Whow does 
mobility into and out of the EU of people and products related to health play out in the rest of the 
world? This latter aspect of the effects of trade and competition on EU health policy also falls 
ŽƵƚƐŝĚĞƚŚĞƐĐŽƉĞŽĨůĞŵĞŶƐĞƚĂů ?ƐƉŝĞĐĞ ? 
Although Clemens et al do not adopt as wide a scope as sketched here, their focus, excluding areas 
such as human rights in health policies, public health protection, and the Eh ?ƐŐůŽďĂůŚĞĂůƚŚƉŽůŝĐŝĞƐ ?
is sufficiently wide for their conclusions to be persuasive nonetheless.  
 
Multiple logics of EU health policy 
Clemens et al stress how their examples highlight multiple logics inherent in EU health policy. They 
note that  W contƌĂƌǇ ƚŽ ƚŚĞ ŐĞŶĞƌĂů ƚĞŶŽƌ ŽĨ ƚŚĞ ŚĞĂůƚŚ ƉŽůŝĐǇ ĐŽŵŵƵŶŝƚǇ ?Ɛ ǀŝĞǁƐ  W no dominant 
ŶĂƌƌĂƚŝǀĞ ĨŽƌ ĚŝƐĐƵƐƐŝŶŐ h ŚĞĂůƚŚ ƉŽůŝĐǇ ŚĂƐ ǇĞƚ ĞŵĞƌŐĞĚ ? dŚĞ ĚŝƐĐŽƵƌƐĞ ŽĨ  ‘ĐŽŶƐƚŝƚƵƚŝŽŶĂů
ĂƐǇŵŵĞƚƌǇ ? ?ƚŚĂƚƚŚĞh ?s powers to Europeanize economic policies are more complete than those 
for social policies) runs strong in EU health policy. But other logics are also expressed. Furthermore, 
it is not clear whether  ‘health ? ĐŽƵŶƚƐĂƐŽŶůǇ ‘ƐŽĐŝĂů ?ŽƌĂůƐŽĂƐ ‘ĞĐŽŶŽŵŝĐ ? ? 
In our forthcoming book (2015), McHale and I also approach EU health through multiple logics. We 
consider the themes of consumerism; (human) rights; interfaces between competition, solidarity 
and equality; and risk. We isolate, compare and contrast an individual perspective and a systemic or 
ĐŽůůĞĐƚŝǀĞƉĞƌƐƉĞĐƚŝǀĞ ?ĂŶĚǁĞĐŽŶƐŝĚĞƌƚŚĞh ?ƐŝŶƚĞƌŶĂůŚĞĂůƚŚůĂǁĂŶĚŝƚƐŝŶƚĞƌĂĐƚŝŽŶƐǁŝƚŚŐůŽďĂů
health law.  Like Clemens et al, we find support for the standard narrative about EU health law and 
policy. We conclude that opportunities for EU health policy to improve health are missed. In Europe, 
the values of solidarity and equality of access according to medical need underpin health systems  W 
and it follows that opposing values, such as mobility, consumer choice or competition, or risk within 
a market, sit ill with health policy communities.  But we also find  W in common with Clemens et al  W 
that the dominant narrative is not the whole of the story.  EU health policy itself expresses and 
embodies a range of values.  
 
Europeanisation of health policy 
/ƐŚĞĂůƚŚƉŽůŝĐǇďĞĐŽŵŝŶŐ ‘ƵƌŽƉĞĂŶŝƐĞĚ ? ?The answer depends upon how the scope of health policy 
is drawn. It is highly improbable that EU health policy will ever have the same substantive scope or 
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dominant focus as national health policies.  But the EU at least touches upon virtually every aspect 
of such policies.  In some areas (such as pharmaceuticals regulation), policies and laws are entirely 
EU-determined.  By contrast, in others (such as end-of-life care), the EU (as opposed to the Council 
of Europe) barely has any influence at all.  It is equally improbable that EU health policy will emerge 
ĂƐĂƐŝŵƉůĞƌĞŐŝŽŶĂůǀĂƌŝĂŶƚŽĨŐůŽďĂůŚĞĂůƚŚ ?ĚŝƐƚŝŶĐƚŝǀĞůǇ ‘ƵƌŽƉĞĂŶ ?ĂƉƉƌŽĂĐŚƚŽƚŚĞŵŽĚŝĨŝĐĂƚŝŽŶ
of liberal global trade involves conceptualising health as a productive factor in economic growth, but 
also embodies human-rights conditionality, elements of an ethic of equality, and risk-based 
consumer protection, particular from products known to be dangerous to health and costly for 
national health systems. 
 
Conclusion 
ůĞŵĞŶƐ Ğƚ Ăů ĐŽŶĐůƵĚĞ ƚŚĂƚ ŝƚ ŝƐ ƚŽŽ ƐŽŽŶ ƚŽ ƐĂǇ ǁŚĞƚŚĞƌ ƚŚĞ  ‘ƉĂƚĐŚǁŽƌŬ ? ŽĨ h ŚĞĂůƚŚ ƉŽůŝĐǇ ŝƐ
becoming ever more coherent, and we are seeing a process of Europeanisation, or whether the 
policy field will remain driven by multiple logics. I would say that the two are not mutually exclusive: 
we are seeing Europeanisation of a policy area that is driven by one dominant (and other subsidiary) 
logics at national level, but by multiple equally dominant logics at the level of the European Union. 
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